Literature DB >> 12518372

Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases.

Hiroki Hirabayashi1, Sohei Ebara, Tetsuya Kinoshita, Yohei Yuzawa, Isao Nakamura, Jun Takahashi, Mikio Kamimura, Kuniyoshi Ohtsuka, Kunio Takaoka.   

Abstract

BACKGROUND: The authors sought to identify treatment-related factors that influenced survival after surgical treatment for metastatic spinal tumors and to evaluate the relationship between survival and postoperative ambulation time as a factor related to quality of life.
METHODS: The medical records of 81 patients with metastatic spinal tumors who underwent palliative surgery at the study institution were assessed. Univariate analysis for factors influencing survival used the Kaplan-Meier log rank statistic and multivariate analysis used the Cox proportional hazards model. The Spearman correlation test was used to analyze the relationship between postoperative ambulation and survival time.
RESULTS: The patients had a median age of 59.9 years and a median survival of 10.6 months after surgery. For patients, postoperative ambulatory median survival was 16.5 months and median ambulation time was 13.8 months. By univariate analysis, anatomic site of the primary tumor, postoperative ambulation, and combined adjuvant therapy (chemotherapy plus radiotherapy) were associated with prolonged survival (P < 0.05). Multivariate analysis identified primary site and postoperative ambulatory function as independent predictors of prolonged survival (P < 0.0001). Significant correlations were found between ambulation time and survival time of patients who were able to walk after surgery (P < 0.0001), even in patients with liver (P < 0.05) or lung carcinoma (P < 0.05).
CONCLUSIONS: The anatomic site of primary carcinoma and postoperative ambulation were associated with longer survival after palliative surgery for metastatic spinal tumor. When ambulation is attained after surgery, it can be preserved until late in remaining life even when the primary tumor is unfavorable. Palliative surgery for spinal metastasis can improve the quality and quantity of life. Copyright 2003 American Cancer Society

Entities:  

Mesh:

Year:  2003        PMID: 12518372     DOI: 10.1002/cncr.11039

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  45 in total

1.  Clinical profile of long-term survivors of breast or thyroid cancer with metastatic spinal tumours.

Authors:  Y Kasai; E Kawakita; A Uchida
Journal:  Int Orthop       Date:  2006-04-26       Impact factor: 3.075

Review 2.  Metastatic epidural cord compression.

Authors:  Thomas N Byrne
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 3.  Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence.

Authors:  Zach Pennington; A Karim Ahmed; Camilo A Molina; Jeffrey Ehresman; Ilya Laufer; Daniel M Sciubba
Journal:  Ann Transl Med       Date:  2018-03

Review 4.  Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group.

Authors:  David Choi; A Crockard; C Bunger; J Harms; N Kawahara; C Mazel; R Melcher; K Tomita
Journal:  Eur Spine J       Date:  2009-12-29       Impact factor: 3.134

5.  Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression.

Authors:  M Ohashi; T Hirano; K Watanabe; K Katsumi; H Shoji; A Sano; H Tashi; I Takahashi; M Wakasugi; Y Shibuya; N Endo
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

6.  Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?

Authors:  Koichi Ogura; Tabu Gokita; Yusuke Shinoda; Hirotaka Kawano; Tatsuya Takagi; Keisuke Ae; Akira Kawai; Rikard Wedin; Jonathan A Forsberg
Journal:  Clin Orthop Relat Res       Date:  2017-05-30       Impact factor: 4.176

7.  Management of metastatic spinal cord compression: awareness of NICE guidance.

Authors:  F M Brooks; Ameet Ghatahora; M C Brooks; Hazel Warren; Laura Price; Pranter Brahmabhatt; Saik De Vauvert; Cerys John; Elizabeth Farnworth; Erwina Sulaiman; Sashin Ahuja
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-08

8.  The outcome and survival of palliative surgery in thoraco-lumbar spinal metastases: contemporary retrospective cohort study.

Authors:  R M Nemelc; A Stadhouder; B J van Royen; T U Jiya
Journal:  Eur Spine J       Date:  2014-11       Impact factor: 3.134

9.  Predictive value of seven preoperative prognostic scoring systems for spinal metastases.

Authors:  Andreas Leithner; Roman Radl; Gerald Gruber; Markus Hochegger; Katharina Leithner; Heike Welkerling; Peter Rehak; Reinhard Windhager
Journal:  Eur Spine J       Date:  2008-09-12       Impact factor: 3.134

10.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.